Showing results (141-150 of 304) with videos related to

Sort By:
Pageof 31
Breast (Edinburgh, Scotland)|May 21, 2024
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper"Pierfranco Conte, Eva Ciruelos, Giuseppe Curigliano, et al.
Cancers|January 21, 2022
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and CharacterizationEros Azzalini, Domenico Tierno, Michele Bartoletti, et al.
Clinical Breast Cancer|August 8, 2017
Determinants of Last-line Treatment in Metastatic Breast CancerMarika Cinausero, Lorenzo Gerratana, Elisa De Carlo, et al.
The Oncologist|July 9, 2026
Anti-HER2 Therapies in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisSimone Rota, Paola Di Nardo, Emma Zottarelli, et al.
Plos One|October 26, 2021
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoringMartina Zanchetta, Valentina Iacuzzi, Bianca Posocco, et al.
International Journal of Cancer|June 10, 2026
DPYD and UGT1A1 Genotype-Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant-Specific Impact on Treatment Intensity and ToxicityMartina Gambron, Elena Peruzzi, Samantha Perfler, et al.
Critical Reviews in Oncology/Hematology|April 28, 2023
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectivesMarco de Scordilli, Anna Michelotti, Diego Zara, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumorsAngela V D'Elia, Gianluca Tell, Diego Russo, et al.
International Journal of Molecular Sciences|December 16, 2020
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic OptionsValli De Re, Giulia Brisotto, Ombretta Repetto, et al.
Pageof 31